G Turashvili
Overview
Explore the profile of G Turashvili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukherjee A, Russell R, Chin S, Liu B, Rueda O, Ali H, et al.
NPJ Breast Cancer
. 2018 Mar;
4:5.
PMID: 29532008
The integration of genomic and transcriptomic profiles of 2000 breast tumours from the METABRIC [Molecular Taxonomy of Breast Cancer International Consortium] cohort revealed ten subtypes, termed integrative clusters (IntClust/s), characterised...
2.
Koti M, Siu A, Clement I, Bidarimath M, Turashvili G, Edwards A, et al.
Br J Cancer
. 2015 Dec;
113(12):1746.
PMID: 26695556
No abstract available.
3.
Koti M, Siu A, Clement I, Bidarimath M, Turashvili G, Edwards A, et al.
Br J Cancer
. 2015 Apr;
112(7):1215-22.
PMID: 25826225
Background: Chemotherapy resistance is a major determinant of poor overall survival rates in high-grade serous ovarian cancer (HGSC). We have previously shown that gene expression alterations affecting the NF-κB pathway...
4.
Burkadze G, Khardzeishvili O, Gudadze M, Tsikhiseli G, Turashvili G
Georgian Med News
. 2010 Sep;
(184-185):51-60.
PMID: 20834076
Immunohistochemically detected BRCA1 positivity has been reported to indicate the presence of full-length functional protein, while immunohistochemical negativity may be a result of sporadic BRCA1 mutation. We set out to...
5.
Dawson S, Makretsov N, Blows F, Driver K, Provenzano E, Le Quesne J, et al.
Br J Cancer
. 2010 Jul;
103(5):668-75.
PMID: 20664598
Background: Breast cancer is heterogeneous and the existing prognostic classifiers are limited in accuracy, leading to unnecessary treatment of numerous women. B-cell lymphoma 2 (BCL2), an antiapoptotic protein, has been...
6.
Turashvili G, Bouchalova K, Bouchal J, Kolar Z
Cesk Patol
. 2007 Sep;
43(3):87-92.
PMID: 17821836
E-cadherin (E-CD) is an epithelial-specific cell adhesion molecule, whose expression is lost in invasive lobular (ILC) but not in invasive ductal carcinoma (IDC) of the breast. This cell adhesion system...
7.
Dvalishvili I, Charkviani L, Turashvili G, Burkadze G
Georgian Med News
. 2006 Apr;
(132):24-7.
PMID: 16636372
The aim of this study was to compare clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grades. We have studied 104 postmenopausal women with a histological diagnosis...
8.
Vacharadze K, Burkadze G, Turashvili G, Kiria N
Georgian Med News
. 2005 Dec;
(128):91-3.
PMID: 16369075
The aim our study was to assess the usefulness of AgNOR stain in distinguishing between benign and malignant mesothelial lesions. The patients were divided into three groups: group I --...
9.
Dvalishvili I, Charkviani L, Turashvili G, Burkadze G
Georgian Med News
. 2005 Dec;
(128):17-21.
PMID: 16369055
The aim of our study was to evaluate the association between the expression of E-cadherin and clinical prognostic factors in uterine endometrioid adenocarcinoma of different histological grade. We have studied...
10.
Dvalishvili I, Charkviani L, Charkviani T, Turashvili G, Burkadze G
Georgian Med News
. 2005 Oct;
(126):27-31.
PMID: 16234588
The aim of our study was to evaluate the association between the expression of cathepsin D and clinical prognostic data in endometrioid adenocarcinoma of different histological grade. We studied 104...